{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:47:42Z","timestamp":1787071662968,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.4103\/ijo.ijo_949_25","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:01:12Z","timestamp":1758801672000},"page":"1545-1547","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Compliance to atropine for myopia progression and its socioeconomic and behavioral determinants"],"prefix":"10.4103","volume":"73","author":[{"given":"Rohan","family":"Arora","sequence":"first","affiliation":[{"name":"General Ophthalmology Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Bisani","sequence":"additional","affiliation":[{"name":"Paediatric Ophthalmology and Adult Strabismus Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Chandrasekaran","sequence":"additional","affiliation":[{"name":"Paediatric Ophthalmology and Adult Strabismus Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Settu","sequence":"additional","affiliation":[{"name":"Paediatric Ophthalmology and Adult Strabismus Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogapriya","family":"Vijayaragavan","sequence":"additional","affiliation":[{"name":"Paediatric Ophthalmology and Adult Strabismus Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: Continued versus washout: Phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: Myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","article-title":"Update in myopia and treatment strategy of atropine use in myopia control","volume":"33","author":"Wu","year":"2019","journal-title":"Eye"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.4103\/ijo.IJO_3354_20","article-title":"Compliance in usage of low-dose atropine for prevention of progression of myopia in Indian children","volume":"69","author":"Dalal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.18203\/2394-6040.ijcmph20233487","article-title":"Modified Kuppuswamy socioeconomic scale 2023: Stratification and updates","volume":"11","author":"Radhakrishnan","year":"2023","journal-title":"Int J Community Med Public Health"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol Health"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ophtha.2009.10.038","article-title":"Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma","volume":"117","author":"Rees","year":"2010","journal-title":"Ophthalmology"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40135-022-00292-6","article-title":"Barriers to care in the treatment of glaucoma: Socioeconomic elements that impact the diagnosis, treatment, and outcomes in glaucoma patients","volume":"10","author":"Musa","year":"2022","journal-title":"Curr Ophthalmol Rep"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","article-title":"Doctor\u2013patient communication, health-related beliefs, and adherence in glaucoma: Results from the glaucoma adherence and persistency study","volume":"115","author":"Friedman","year":"2008","journal-title":"Ophthalmology"},{"key":"R14-20260420","first-page":"26869","article-title":"The impact of socioeconomic status, race\/ethnicity, and patient perceptions on medication adherence in depression treatment","volume":"22","author":"Chawa","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1164\/ajrccm.157.6.9712007","article-title":"Adherence with twice-daily dosing of inhaled steroids: Socioeconomic and health-belief differences","volume":"157","author":"Apter","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4103\/2141-9248.144914","article-title":"Determinants of patient\u2019s adherence to hypertension medications: Application of health belief model among rural patients","volume":"4","author":"Kamran","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s40123-023-00797-8","article-title":"Factors affecting glaucoma medication adherence and interventions to improve adherence: A narrative review","volume":"12","author":"Moore","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17469899.2016.1134318","article-title":"Systematic review of educational interventions to improve glaucoma medication adherence: An update in 2015","volume":"11","author":"Newman-Casey","year":"2016","journal-title":"Expert Rev Ophthalmol"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ogla.2020.04.013","article-title":"The impact of the support, educate, empower personalized glaucoma coaching pilot study on glaucoma medication adherence","volume":"3","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"R20-20260420","first-page":"786","article-title":"Medication monitoring and optimization: A targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence","volume":"20","author":"van Boven","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/10807680260362687","article-title":"Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study","volume":"18","author":"Taylor","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"issue":"Suppl 1","key":"R22-20260420","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.4103\/0301-4738.73693","article-title":"Compliance and adherence in glaucoma management","volume":"59","author":"Robin","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"R23-20260420","first-page":"4506","article-title":"Self\u2013reported patient compliance within the European Glaucoma Prevention Study","volume":"45","author":"Troost","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/jop.2018.0134","article-title":"Patient-reported nonadherence with glaucoma therapy","volume":"35","author":"Wolfram","year":"2019","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_949_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:38Z","timestamp":1787068238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_949_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_949_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}